Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer

Published:2019-02 Issue: Volume:192 Page:109-117
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Chung Seung Woo,Cho Young Seok,Choi Jeong Uk,Kim Ha Rin,Won Tae Hyung,Kim Sang Yoon,Byun Youngro

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future planning

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference48 articles.

1. Radiation oncology: a century of achievements;Bernier;Nat. Rev. Canc.,2004

2. Recent advances in radiation oncology;Garibaldi;Ecancermedicalscience,2017

3. Characterization of a novel prostate-specific antigen-activated peptide-doxorubicin conjugate in patients with prostate cancer;DiPaola;J. Clin. Oncol.,2002

4. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys;Sapra;Clin. Canc. Res.,2005

5. Drug targeting and tumor heterogeneity;Bae;J. Contr. Release,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment;Frontiers in Pharmacology;2024-07-31

2. A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs;Biomaterials Research;2023-12-15

3. A Versatile Platform to Generate Prodrugs with Rapid and Precise Albumin Hitchhiking and High Cargo Loading for Tumor‐Targeted Chemotherapy;Small;2023-11-14

4. Letter-to-editor, “Feedback amplification of senolysis using caspase-cleavable peptide-doxorubicin conjugate and 2DG” [Journal of Controlled Release, Volume 346, pp. 158-168, (2022), doi: 10.1016/j.jconrel.2022.04.012].;Journal of Controlled Release;2023-10

5. Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications;Biomedicine & Pharmacotherapy;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3